LED Medical Inc. Announces Distribution Agreement with Patterson Dental

BURNABY, BRITISH COLUMBIA--(Marketwired - Jan. 21, 2014) - LED Medical Diagnostics Inc. ("LED Medical" or the "Company") (TSX VENTURE:LMD) (OTCQX:LEDIF) (FRANKFURT:LME) is pleased to announce that its wholly-owned U.S. subsidiary, LED Dental Inc. ("LED Dental"), has entered into a non-exclusive partnership with Patterson Dental for the distribution of the company's VELscope® Vx Enhanced Oral Assessment System and product line within the US and Canadian markets.

"We are pleased to welcome Patterson Dental as our newest U.S. distribution partner for the VELscope® Vx family of products," stated Dr. David Gane, CEO of LED Medical. "Patterson Dental is one of the most respected names in North America, with an exemplary reputation for providing innovative products and focusing on the success of its customers," added Dr. Gane. "With more than 85 branch offices nationwide and over 1,500 sales representatives and equipment specialists, Patterson Dental is a valued distribution partner for LED Dental."

"The VELscope® Vx product line is an important addition to the wide range of products we provide to our customers," states Paul Guggenheim, president of Patterson Dental. "With its powerful and proven tissue fluorescence technology, the VELscope® Vx device provides important visual information that can help dentists detect oral abnormalities sooner than with the naked eye. We are excited to bring this product to our customers to supplement the high level of oral care they already provide."

About the VELscope® Vx Enhanced Oral Assessment System

The distinctive blue-spectrum light of the VELscope® Vx hand-held device causes the soft tissues of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns that are visibly disrupted by trauma or disease, such as neoplastic lesions, chemical irritation, side-effects from medication, thermal damage, fungal, viral or bacterial infections. Use of the VELscope® Vx allows a wide variety of oral abnormalities to be discovered, often before they're visible to the unassisted eye. It is also the only tissue fluorescence device with photo/video documentation capabilities through the viewing mechanism, a key function for referrals and patient records.